2026. In Silico Design, ADMET Prediction and Molecular Docking Studies of Novel Cyanopyridine-Substituted 1,3,5-Triazine Derivatives as Potential Anti-Alzheimer Agents. MEDICARE CHURNING International Journal of Medical Science, Healthcare & Research Innovations. 1, 2 (Jul. 2026), 16–39.